Estimating the world cancer burden: Globocan 2000

International Journal of Cancer

Volumn 94, Issue 2, 2001, Pages 153-156

  Maxwell Parkin, D ^a   Bray, Freddie ^a   Ferlay, Jacques ^a   Pisani, Paola ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; HUMAN; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY;

FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PREVALENCE; TIME FACTORS;

EID: 0035888074     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1440     Document Type: Short Survey

References (33)

1. Estimates of worldwide frequency of sixteen major cancers in 1980
2. Estimates of worldwide incidence of eighteen major cancers in 1985
3. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention, and projections of future burden
4. Estimates of the worldwide incidence of twenty-five major cancers in 1990
5. Estimates of the worldwide mortality from twenty-five major cancers in 1990. Implications for prevention, and projections of future burden
6. Global regional mortality patterns by cause of death in 1980
7. Estimates and projections of mortality by cause: A global overview, 1970-2015
8. Global mortality, disability, and the contribution of risk factors: Global burden of disease study
9. Nagoya, Japan University of Nagoya Press (for UICC)
10. Estimates of the worldwide incidence of twenty-five major cancers in 1990
11. Estimates of the worldwide prevalence of cancer for twenty-five sites in the adult population
12. Incidence, mortality or prevalence as indicators of the cancer problem
13. The prevalence of cancer estimates based upon the Connecticut Tumor Registry
14. Cancer in the Nordic countries 1981-1992
15. Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey
16. Breast cancer incidence and prevalence estimated from survival and mortality
17. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and Results (SEER) program
18. Calculating the prevalence of cancer
19. Impact of cancer: Years of life lost due to cancer mortality
20. Quantifying the burden of disease: The technical basis for disability-adjusted life years
21. Health policy approaches to measuring and valuing human life: Conceptual and ethical issues